Find upcoming presentations, industry seminars, conference appearances, CPE events, and symposiums near you!
It can be a challenge for employers to save with employee benefits while offering an attractive compensation package. Read on for options to consider.
Payor innovations require providers to be more proactive and strategic in contract negotiations. Read more about the impact.
Reduce revenue loss and collection re-work costs from insurance denials with FORVIS' Denials Management Monitoring. Read more about the impact.
The annual recertification window for FQHCs and most grantee-type entities opens January 30, 2023 and closes February 27, 2023. Read on for details.
All 340B covered entities that submit claims for separately payable Part B drugs and biologicals face a new requirement starting January 1, 2024.
CMS has announced the final OPPS Rules for 2023, confirming that reimbursement payments for 340B drugs will be restored to ASP plus 6%.
The newly passed Consolidated Appropriations Act of 2023 includes multiple provisions anticipated to impact RHCs. Read on for details.
See how being proactive in monitoring, renegotiating, and seeking competitive bids for contracts is a best practice that could help you save.
The ruling on 340B reimbursement rate in the 2022 OPPS Rule may impact providers participating in APMs.
In this session recap, facets of physician enterprise such as collaboration and the use of Triple-Aim physician contracts are discussed. Read here for details.